| Fentanyl 500 micrograms in 10 ml Solution for Injection PA0073/122/002 |
FENTANYL CITRATE |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Feraccru 30 mg hard capsules EU/1/15/1075/001-004 |
Ferric maltol |
Norgine B.V. |
— |
| Ferriprox 1 000 mg film-coated tablets EU/1/99/108/004-006 |
Deferiprone |
Chiesi Farmaceutici S.p.A. |
— |
| Ferriprox 100 mg/ml oral solution EU/1/99/108/002-003 |
Deferiprone |
Chiesi Farmaceutici S.p.A. |
— |
| Ferriprox 500 mg film-coated tablets EU/1/99/108/001 |
Deferiprone |
Chiesi Farmaceutici S.p.A. |
— |
| Fesoterodine Rowa 4 mg prolonged-release tablets PA0074/091/001 |
Fesoterodine fumarate |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Fesoterodine Rowa 8 mg prolonged-release tablets PA0074/091/002 |
Fesoterodine fumarate |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Fetcroja 1 g powder for concentrate for solution for infusion EU/1/20/1434/001 |
Cefiderocol Sulfate Tosilate |
Shionogi B.V. |
— |
| Fexeric EU/1/15/1039/001 |
Ferric citrate coordination complex |
Akebia Europe Limited |
— |
| Fexo Allergy Relief 120 mg film-coated tablets PA0074/096/001 |
Fexofenadine hydrochloride |
Rowa Pharmaceuticals Limited, |
Marketed |
| Fexofast 120 mg Film-coated Tablets PA1963/014/001 |
Fexofenadine hydrochloride |
Cipla Europe NV |
Not marketed |
| Fexofast 180 mg Film-coated Tablets PA1963/014/002 |
Fexofenadine hydrochloride |
Cipla Europe NV |
Not marketed |
| Fexofenadine Hydrochloride 120 mg Film-coated tablets PA22871/004/002 |
Fexofenadine hydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |
| Fexofenadine Hydrochloride 180 mg Film-coated tablets PA22871/004/003 |
Fexofenadine hydrochloride |
Azure Pharmaceuticals Ltd. |
Marketed |
| Fiasp 100 units/mL FlexTouch solution for injection in pre-filled pen EU/1/16/1160/001-006 |
Insulin aspart |
Novo Nordisk A/S |
— |
| Fibrovein 0.2% Solution for Injection PA22778/002/001 |
Sodium tetradecyl sulfate |
STD Pharmaceutical (Ireland) Limited |
Not marketed |
| Fibrovein 0.5% Solution for Injection PA22778/002/002 |
Sodium tetradecyl sulfate |
STD Pharmaceutical (Ireland) Limited |
Not marketed |
| Fibrovein 1% Solution for Injection PA22778/002/003 |
Sodium tetradecyl sulfate |
STD Pharmaceutical (Ireland) Limited |
Not marketed |
| Fibrovein 3% Solution for Injection PA22778/002/004 |
Sodium tetradecyl sulfate |
STD Pharmaceutical (Ireland) Limited |
Not marketed |
| Filgrastim Hexal 30 MU (60 MU/ml) Solution for injection or infusion EU/1/08/496/1-4 |
Ep2006 (recombinant human granulocyte-colony stimulating factor) |
Hexal AG |
— |
| Filgrastim Hexal 48 MU (96 MU/ml) Solution for injection or infusion EU/1/08/496/5-8 |
Ep2006 (recombinant human granulocyte-colony stimulating factor) |
Hexal AG |
— |
| Filspari 200 mg film-coated tablets EU/1/23/1788/001 |
Sparsentan |
Vifor France |
— |
| Filspari 400 mg film-coated tablets EU/1/23/1788/002-003 |
Sparsentan |
Vifor France |
— |
| Filsuvez EU/1/22/1652/001-002 |
BETULAE CORTEX DRY EXTRACT (5-10 : 1); EXTRACTION SOLVENT: N-HEPTANE 95% (W/W) |
Chiesi Farmaceutici S.p.A. |
— |
| Fingolimod 0.5 mg hard capsules PA0074/086/001 |
Fingolimod |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Fingolimod Accord 0.5 mg hard capsules EU/1/20/1450/001-006 |
FINGOLIMOD HYDROCHLORIDE |
Accord Healthcare S.L.U. |
— |
| Fingolimod Bluefish 0.5 mg hard capsules PA1436/035/001 |
FINGOLIMOD HYDROCHLORIDE |
Bluefish Pharmaceuticals AB |
Not marketed |
| Fingolimod MSN 0.5 mg hard capsules PA23250/007/001 |
Fingolimod |
MSN Labs Europe Limited |
Marketed |
| Fingolimod Mylan 0.5 mg hard capsules EU/1/21/1573/001-024 |
FINGOLIMOD HYDROCHLORIDE |
Mylan Pharmaceuticals Limited |
— |
| Finlee 10 mg dispersible tablets EU/1/23/1767/001-002 |
Dabrafenib Mesylate |
Novartis Europharm Limited |
— |
| Finomel Emulsion for Infusion PA2299/044/002 |
Glycine, Alanine, Arginine, Histidine, Isoleucine |
Baxter Holding B.V. |
Marketed |
| Finomel Peri Emulsion for Infusion PA2299/044/001 |
Alanine, Arginine, Glycine, Histidine, Isoleucine |
Baxter Holding B.V. |
Marketed |
| Fintepla 2.2 mg/ml oral solution EU/1/20/1491/001-004 |
Fenfluramine hydrochloride |
UCB Pharma S.A. |
— |
| Firazyr 30 mg solution for injection in pre-filled syringe EU/1/08/461/001-002 |
Icatibant |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| FIRDAPSE 10 mg tablets EU/1/09/601/001 |
3,4-diaminopyridine phosphate |
SERB S.A. |
— |
| Firmagon 80 mg powder and solvent for solution for injection EU/1/08/504/001 |
Degarelix (as acetate) |
Ferring Pharmaceuticals A/S |
— |
| Firmagon 120 mg powder and solvent for solution for injection EU/1/08/504/002 |
Degarelix (as acetate) |
Ferring Pharmaceuticals A/S |
— |
| Flagyl 400mg Tablets PA0814/003/002 |
Metronidazole |
Fidia Farmaceutici S.p.A. |
Marketed |
| Flagyl-S 200mg/5ml Oral Suspension PA0814/003/001 |
Metronidazole |
Fidia Farmaceutici S.p.A. |
Marketed |
| Flebogamma EU/1/07/404/1-5 |
Human normal immunoglobulin |
Instituto Grifols S.A. |
— |
| Flebogamma DIF EU/1/07/404/006-008 |
Human normal immunoglobulin |
Instituto Grifols S.A. |
— |
| Flector Tissugel 140 mg medicated plaster PA1104/004/001 |
Diclofenac epolamine |
IBSA Farmaceutici Italia S.r.l |
Marketed |
| Flixabi 100 mg powder for concentrate for solution for infusion EU/1/16/1106/001 |
Infliximab |
Samsung Bioepis NL B.V. |
— |
| Fluad suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuvanted) EU/1/24/1878/001-004 |
A/(H1N1)-LIKE VIRUS ANTIGEN, A/(H3N2)-LIKE VIRUS ANTIGEN, B (Victoria lineage)-like virus antigen |
Seqirus Netherlands B.V. |
— |
| Flucelvax suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures) EU/1/24/1879/001-004 |
A/(H1N1)-LIKE VIRUS ANTIGEN, A/(H3N2)-LIKE VIRUS ANTIGEN, B (Victoria lineage)-like virus antigen |
Seqirus Netherlands B.V. |
— |
| Flucloxacillin 1000 mg Film-coated Tablets PA22871/026/002 |
FLUCLOXACILLIN SODIUM |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Flucloxacillin 1000 mg powder for solution for injection/infusion PA2059/069/002 |
FLUCLOXACILLIN SODIUM |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Flucloxacillin 125mg/5ml Oral Solution PA1418/016/003 |
Flucloxacillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Flucloxacillin 125mg/5ml Oral Solution BP PA1418/015/001 |
Flucloxacillin |
Athlone Pharmaceuticals Limited |
Not marketed |
| Flucloxacillin 2000 mg powder for solution for injection/infusion PA2059/069/003 |
FLUCLOXACILLIN SODIUM |
Fresenius Kabi Deutschland GmbH |
Marketed |